blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1485339

EP1485339 - BENZYL ALCOHOL DERIVATIVES AND THEIR USE AS ANTIMICROBIAL AGENTS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  03.04.2009
Database last updated on 03.10.2024
Most recent event   Tooltip03.04.2009Application deemed to be withdrawnpublished on 06.05.2009  [2009/19]
Applicant(s)For all designated states
Ciba Specialty Chemicals Holding Inc.
Klybeckstrasse 141
4057 Basel / CH
[2004/51]
Inventor(s)01 / HÖLZL, Werner
4, rue de l'Argent
F-68440 Eschentzwiller / FR
02 / KOPPOLD, Jürgen
Röttler Strasse 44
79541 Lörrach / DE
03 / MARQUAIS-BIENEWALD, Sophie
63, rue de Hagenthal
F-68220 Hegenheim / FR
04 / PREUSS, Andrea
Hochstrasse 35
CH-4053 Basel / CH
 [2004/51]
Application number, filing date03706613.113.03.2003
[2004/51]
WO2003EP02618
Priority number, dateEP2002040521019.03.2002         Original published format: EP 02405210
[2004/51]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03078367
Date:25.09.2003
Language:EN
[2003/39]
Type: A2 Application without search report 
No.:EP1485339
Date:15.12.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 25.09.2003 takes the place of the publication of the European patent application.
[2004/51]
Search report(s)International search report - published on:EP29.07.2004
ClassificationIPC:C07C43/23, A01N31/14, A61K7/16, A01N55/10, C07C43/253, C07F7/08
[2004/51]
CPC:
A61Q17/005 (EP,US); A01N31/14 (EP,US); A01N31/16 (EP,US);
A01N55/00 (EP,US); A61K8/34 (EP,US); A61P31/02 (EP);
A61Q15/00 (EP,US); A61Q5/00 (EP,US); C07C43/23 (EP,US);
C07C43/253 (EP,US); C07F7/081 (EP,US); A61Q11/00 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2004/51]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
TitleGerman:BENZYLALKOHOLDERIVATE UND IHRE VERWENDUNG ALS ANTIMIKROBIELLE WIRKSTOFFE[2004/51]
English:BENZYL ALCOHOL DERIVATIVES AND THEIR USE AS ANTIMICROBIAL AGENTS[2004/51]
French:DERIVES D'ALCOOL BENZYLIQUE ET LEUR UTILISATION COMME AGENTS ANTIMICROBIENS[2004/51]
Entry into regional phase26.08.2004National basic fee paid 
26.08.2004Designation fee(s) paid 
26.08.2004Examination fee paid 
Examination procedure23.09.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
26.08.2004Examination requested  [2004/51]
01.10.2008Application deemed to be withdrawn, date of legal effect  [2009/19]
03.12.2008Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2009/19]
Fees paidRenewal fee
17.02.2005Renewal fee patent year 03
16.02.2006Renewal fee patent year 04
08.02.2007Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.03.200806   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US5391817  (SPRINGER DANE [US], et al) [X] 6,17 * column 43, line 12 - column 45, line 22 *;
 [X]US4668705  (MOELLER HINRICH [DE], et al) [X] 15,17 * column 3, line 41 *;
 [X]WO0162082  (CIBA SC HOLDING AG [CH], et al) [X] 17 * page 42; example 5B *;
 [X]JP2000191520  ;
 [X]EP1053989  (CIBA SC HOLDING AG [CH]) [X] 1,2,7-13,15,16 * claims 1-12, in particular page 40, lines 16-22 *;
 [A]EP0908553  (CIBA GEIGY AG [CH]) [A] 1,9 * claims 1,8 *;
 [A]WO9801524  (UNILEVER PLC [GB], et al) [A] 1,11 * claim - *;
 [A]US4946865  (TAKAHASHI JUNYA [JP], et al) [A] 1 * claim - *;
 [A]US4663314  (HAYASE YOSHIO [JP], et al) [A] 1 * claim - *
 [X]  - H. . SHAM ET AL, "A novel, picomolar inhibitor of human immunodeficiency virus type 1 protease", JOURNAL OF MEDICINAL CHEMISTRY, WASHINGTON US, (1996), vol. 39, no. 2, pages 392 - 397, XP002218373 [X] 17 * page 396, column 1, paragraph 2 *

DOI:   http://dx.doi.org/10.1021/jm9507183
 [X]  - K. TANAKA ET AL, "Asymmetric reduction with 5-deazaflavin. II. Synthesis of some chiral 5-deazaflavin derivatives", CHEMICAL AND PHARMACEUTICAL BULLETIN., TOKYO JP, (1990), vol. 38, no. 2, pages 312 - 317, XP002218374 [X] 17 * page 315, column 2, paragraph 4 *
 [X]  - E PROFFT, "o-Vanilin and novovanillin (2-hydroxy-3-ethoxybenzaldehyde). II. 2,3-Dialkoxyphenyl-beta-ethylamines", CHEMICAL ABSTRACTS, (19591010), vol. 53, no. 19, column 17941e, XP002218376 [X] 17 * abstract *
    [ ] - ARCH. PHARM., (1959), vol. 292, pages 70 - 75
 [X]  - A. NAKAZATO ET AL, "Design, synthesis, structure-activity relationships, and biological characterization of novel arylalkoxyphenylalkylamine sigma ligands as potential antipsychotic drugs", JOURNAL OF MEDICINAL CHEMISTRY, WASHINGTON US, (1999), vol. 42, no. 6, pages 1076 - 1087, XP002218375 [X] 6,17 * page 1083, column 2, paragraph 2 - paragraph 3 *

DOI:   http://dx.doi.org/10.1021/jm980212v
 [X]  - DATABASE WPI, 1, Derwent World Patents Index, vol. 00, no. 50, Database accession no. 2000-545825, XP002261555 & JP2000191520 A 00000000 (SAKUMA) [X] 1,2,4,5,7-13,15,16 * abstract *
 [A]  - D. REHN UND H. NOLTE, "Zur antimikrobiellen Wirksamkeit subtituierter aromatischer Aldehyde und Alkohole", ZBL. BAKT. HYG., I. ABT. ORIG. B, (1979), vol. 168, pages 507 - 516, XP000617375 [A] 1 * Tabelle 1, Verbindung Nr. 34 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.